These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24236)

  • 1. [Clinical aspects of the graft-versus host disease (author's transl)].
    Górski A
    Przegl Lek; 1977; 34(12):861-4. PubMed ID: 24236
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 3. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Emergency problems of the graft vs host reaction (literature survey)].
    Shevelev AS
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention or reduction of GVH reaction: physical separation of immunocompetent cells and immunosuppressive potential of antithymocyte serum.
    Harada M
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):909-19. PubMed ID: 24976
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation: introduction.
    Mathé G; Oldham R
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract]   [Full Text] [Related]  

  • 8. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
    Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

  • 10. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of immune reactions by antilymphocyte serum.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1978 Mar; 10(1):23-9. PubMed ID: 24907
    [No Abstract]   [Full Text] [Related]  

  • 13. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease.
    Gupta S; Kapoor N; O'Reilly R; Good RA
    J Clin Lab Immunol; 1984 Aug; 14(4):173-5. PubMed ID: 6238167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on bone marrow transplantation. The effect of antilymphocyte globulin (ALG) on hemopoietic stem cells (author's transl)].
    Fujita S; Kai S; Hamano T; Nagai K; Hara H
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):428-35. PubMed ID: 386693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.